EBI-001

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEBI-001
Drug Alias NameEBI-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionβ-glucosidase inhibitorsHepatitis B virus inhibitors
TargetsHepatitis B virusβ-glucosidase
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of OxfordSynergy Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of OxfordEmergent Biosolutions IncSynergy Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A